ClearTrial Thought Leadership Showcased at DIA 46th Annual Meeting

Share Article

Four ClearTrial industry experts selected to speak on leading trends in Clinical Operations, Finance, Outsourcing, and Project Management at industry's most prestigious conference

ClearTrial (http://www.cleartrial.com), the leading provider of Clinical Trial Operations (CTO) software, announced today that four ClearTrial industry experts have been selected to share their clinical knowledge and experience on the podium at the DIA 46th Annual Meeting in Washington, DC. The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and lifecycle management of pharmaceuticals, medical devices, and related products.

ClearTrial industry experts will present the following topics covering clinical operations, finance, outsourcing, and project management:

“Adaptive Trials: Too Complicated for Little Return?”
Molly Blake-Michaels, Director, Clinical Services
Tuesday, June 15, 4:00-5:30 p.m.

“Financial Accruals for Clinical Trials: Basic Concepts and Effective Accrual Models”
Michael Bruns, Chief Financial Officer
Wednesday, June 16, 10:30 a.m.-12:00 p.m.

“Proven Methods for Reducing Change Orders and Accurately Assessing Their Impact”
Mindy Davis (Session Chair), Director, Clinical Services
Tuesday, June 15, 4:00-5:30 p.m.

“Implementing Earned Value Management in Clinical Operations: Case Studies”
Kristin Forrest (Session Chair), Director, Clinical Services
Monday, June 14, 3:30-5:00 p.m.

“We're honored to have been selected to add our voices to some of the most pressing discussions in clinical development at the DIA Annual Meeting,” stated ClearTrial CEO Mike Soenen. “The range of topics to which we are speaking is a testament to the breadth and depth of industry expertise within ClearTrial – expertise which is applied on behalf of our customers every day, and which helps make ClearTrial software uniquely suited to the clinical environment.”

In addition to its thought leadership on the podium, ClearTrial will be displaying its newest software release, ClearTrial v3.2, in the DIA exhibit hall. ClearTrial v3.2 enables organizations to achieve greater control and increased accuracy when managing complex, global clinical studies. The software includes a number of new features and product enhancements that provide for greater accuracy in forecasting – improving on the leading standard established by ClearTrial, which has been benchmarked to 1-5% accuracy when compared with actual study costs.

For global studies and for trial sponsors entering new and emerging countries to conduct trials, ClearTrial v3.2 expands on the software's already extensive, country-specific clinical intelligence. By including labor rates for each country, as well as intelligence around tasks affecting study timelines – such as site activation and regulatory delays – ClearTrial v3.2 makes it easier to model "what-if" scenarios and to generate fast and accurate forecasts of study costs, resource demand, and timelines in any region.

ClearTrial v3.2 Being Put to the Test at DIA

In a unique demonstration of confidence in the speed and accuracy of ClearTrial software, the company is providing a limited number of complimentary study plans for eligible trial sponsors. Sponsors will be asked to simply bring a few key study assumptions, such as the number of sites, to ClearTrial's booth #1229. A ClearTrial representative will enter the assumptions into ClearTrial v3.2 and generate an accurate study budget, resource demand forecast and milestone date projection -- all in 15 minutes.

“For most sponsors, clinical trial budgeting and resource planning is a frustrating, expensive process with turnaround times measured in weeks or even months,” observed Andrew Grygiel, VP of Marketing and Product Management at ClearTrial. “For ClearTrial customers, creating accurate, comprehensive clinical plans based on their own clinical assumptions can be accomplished in minutes. No other software on the market can make that same claim.”

If you are a trial sponsor and would like to be considered for a free 15-minute study budget, please email dia(at)cleartrial(dot)com.

The DIA 46th Annual Meeting will be held at the Walter E. Washington Convention Center, June 13-17, in Washington, DC. For more information and to register, please visit http://www.diahome.org/diahome/FlagshipMeetings/home.aspx?meetingid=20751.

About ClearTrial®
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, linking clinical planning, forecasting, and tracking of operational and financial performance in a single, integrated system. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

For more information contact:

Mike Lange
ClearTrial
+1 630.986.9800 x112
mlange(at)cleartrial(dot)com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Fitzmaurice
ClearTrial
630-986-9800 ext. 131
Email >
Visit website